Published in J Virol on July 01, 2004
Adaptive immune features of natural killer cells. Nature (2009) 8.46
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med (2008) 1.86
The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat Immunol (2014) 1.77
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 1.45
Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol (2009) 1.42
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Complete sequence determination of a novel reptile iridovirus isolated from soft-shelled turtle and evolutionary analysis of Iridoviridae. BMC Genomics (2009) 1.40
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol (2008) 1.33
Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J Immunol (2009) 1.32
Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity (2009) 1.29
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity (2014) 1.24
Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med (2013) 1.21
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J Virol (2011) 1.20
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med (2009) 1.16
Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog (2012) 1.13
Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol (2006) 1.13
A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS One (2011) 1.08
The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J Virol (2011) 1.07
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Conditional cytomegalovirus replication in vitro and in vivo. J Virol (2005) 1.03
Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection. J Immunol (2009) 1.02
Dominant negative mutants of the murine cytomegalovirus M53 gene block nuclear egress and inhibit capsid maturation. J Virol (2010) 1.01
All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends Mol Med (2011) 1.01
The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation. J Virol (2008) 1.01
Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nat Immunol (2012) 0.99
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res (2013) 0.99
Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50. J Virol (2007) 0.98
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol (2007) 0.98
Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. J Exp Med (2011) 0.98
Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur J Immunol (2010) 0.98
The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors. Viruses (2009) 0.97
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
MicroRNA function in NK-cell biology. Immunol Rev (2013) 0.96
Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice. Cancer Res (2012) 0.96
Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol (2009) 0.95
Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol (2006) 0.93
Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog (2014) 0.93
Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med (2014) 0.92
CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J Virol (2013) 0.91
Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control. Front Immunol (2014) 0.91
Ly49 receptors: innate and adaptive immune paradigms. Front Immunol (2014) 0.91
M94 is essential for the secondary envelopment of murine cytomegalovirus. J Virol (2011) 0.90
How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol (2011) 0.90
Disruption of murine cardiac allograft acceptance by latent cytomegalovirus. Am J Transplant (2008) 0.89
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol (2014) 0.88
Evidence for natural killer cell memory. Curr Biol (2013) 0.88
Nodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lung. PLoS Pathog (2013) 0.88
Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Med Microbiol Immunol (2012) 0.86
Markers of nonselective and specific NK cell activation. J Immunol (2013) 0.86
Natural killer cells in immunodefense against infective agents. Expert Rev Anti Infect Ther (2008) 0.86
Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. J Clin Invest (2014) 0.86
Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J Exp Med (2014) 0.86
Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog (2014) 0.85
CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection. Viral Immunol (2009) 0.85
The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses. J Biomed Biotechnol (2011) 0.84
Mice with asthma are more resistant to influenza virus infection and NK cells activated by the induction of asthma have potentially protective effects. J Clin Immunol (2011) 0.83
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals. PLoS Genet (2011) 0.82
Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol (2011) 0.81
Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infections. Front Microbiol (2014) 0.81
Conditional gene expression systems to study herpesvirus biology in vivo. Med Microbiol Immunol (2008) 0.81
A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection. J Virol Methods (2007) 0.81
Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands. J Virol (2013) 0.81
Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution. PLoS Pathog (2013) 0.80
VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice. PLoS One (2013) 0.79
Cardif (MAVS) Regulates the Maturation of NK Cells. J Immunol (2015) 0.79
Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice. PLoS Pathog (2015) 0.78
Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus. PLoS Pathog (2015) 0.78
Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection. J Exp Med (2016) 0.78
Genetic dissection of NK cell responses. Front Immunol (2013) 0.77
Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. Mamm Genome (2010) 0.77
Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization. Viruses (2009) 0.77
TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus. Transplantation (2009) 0.77
The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection. Med Microbiol Immunol (2015) 0.77
Modeling cytomegalovirus infection in mouse tumor models. Front Oncol (2015) 0.76
Intrinsic Contribution of Perforin to NK-Cell Homeostasis during Mouse Cytomegalovirus Infection. Front Immunol (2016) 0.75
The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition. PLoS One (2013) 0.75
Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection. J Exp Med (2016) 0.75
Reduced MCMV Δm157 viral clearance in the absence of TSAd. Sci Rep (2015) 0.75
Heterologous immunity and persistent murine cytomegalovirus infection. J Virol (2016) 0.75
Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1ε with NK Cells Impacts NKG2D Expression and Function. Immunohorizons (2017) 0.75
IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection. PLoS Pathog (2017) 0.75
Redefining Memory: Building the Case for Adaptive NK cells. J Virol (2017) 0.75
Natural Killer Cell Memory: Progress and Implications. Front Immunol (2017) 0.75
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus. PLoS Pathog (2017) 0.75
Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection. J Immunol (2017) 0.75
Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice. PLoS Pathog (2017) 0.75
Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene (1995) 15.67
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol (1999) 9.55
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol (1985) 4.76
Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol (1999) 4.23
Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 4.18
Specific and nonspecific NK cell activation during virus infection. Nat Immunol (2001) 4.02
Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet (2001) 3.96
The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity (2002) 3.85
Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma (1984) 3.68
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (1997) 2.63
Natural killer cells and viral infections. Curr Opin Immunol (2003) 2.63
Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med (1998) 2.60
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med (1990) 2.55
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol (1997) 2.35
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun (1981) 2.08
The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol (1992) 2.08
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol (1998) 2.06
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol (1990) 1.99
Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps. Mamm Genome (1999) 1.91
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 1.85
Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol (1995) 1.77
Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics (1995) 1.76
Viral evasion of natural killer cells. Nat Immunol (2002) 1.74
Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem (1998) 1.68
Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med (2000) 1.65
Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med (2003) 1.37
Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med (2002) 1.33
NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens (2003) 1.30
The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. J Immunol (1998) 1.16
Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol (2001) 1.15
Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics (1999) 1.14
Virus-driven evolution of natural killer cell receptors. Microbes Infect (2002) 1.10
Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol (1999) 1.08
Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance. J Virol (2002) 1.06
Successful control of viruses by NK cells--a balance of opposing forces? Trends Microbiol (2002) 1.06
High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics (1997) 1.05
Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. Nat Immun (1995) 1.01
Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity. J Virol (2000) 1.00
Natural killer cells: stress out, turn on, tune in. Curr Biol (1999) 0.97
The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics (1997) 0.94
Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity (2004) 4.50
In vivo developmental stages in murine natural killer cell maturation. Nat Immunol (2002) 4.25
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
The dynamic life of natural killer cells. Annu Rev Immunol (2004) 3.96
Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol (2002) 3.20
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg (2003) 3.12
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol (2002) 2.92
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Natural killer cells and viral infections. Curr Opin Immunol (2003) 2.63
Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 2.61
Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg (2007) 2.51
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol (2002) 2.26
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res (2009) 2.26
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
NKG2D function protects the host from tumor initiation. J Exp Med (2005) 2.19
TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol (2007) 2.17
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol (2007) 2.12
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol (2003) 2.09
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97
MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med (2010) 1.95
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med (2008) 1.86
TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol (2007) 1.85
Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 1.85
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol (2005) 1.85
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 1.85
Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev (2006) 1.82
How do natural killer cells find self to achieve tolerance? Immunity (2006) 1.74
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med (2009) 1.68
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
Induction of natural killer cell responses by ectromelia virus controls infection. J Virol (2007) 1.62
Viruses know it all: new insights into IFN networks. Trends Immunol (2005) 1.62
2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62
Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep (2009) 1.60
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Natural killer cell tolerance licensing and other mechanisms. Adv Immunol (2009) 1.60
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol (2005) 1.55
Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol (2013) 1.54
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol (2005) 1.53
Is there still a role for total pancreatectomy? Ann Surg (2007) 1.52
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
Immune evasion of natural killer cells by viruses. Curr Opin Immunol (2008) 1.51
Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol (2012) 1.49
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe (2009) 1.48
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 1.45
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood (2008) 1.45
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol (2003) 1.43
MHC Class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70, 1992. J Immunol (2006) 1.43
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J Immunol (2005) 1.42
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol (2009) 1.40
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med (2004) 1.35
Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol (2013) 1.35
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med (2007) 1.34
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood (2008) 1.34
Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med (2003) 1.34
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology (2003) 1.32
IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol (2006) 1.31